This year’s Keynote Lecture was delivered by Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester.
This programme of work had been created by experts in stroke and vascular dementia working with people affected by both conditions. This research programme aims to find out who will develop memory and thinking problems after stroke, why this happens, and how we can treat these issues.
In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. This could create new treatments for CADASIL, and allow us to better understand the way that gene mutation causes disease.
Exploring the causes of ‘jargon speech’ through electrophysiology and using it to help stroke survivors that deal with it.
Currently, a drug called alteplase is used in thrombolysis, but the researchers think that another drug, called tenecteplase, may be more effective than alteplase.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Thousands of lives a year could be changed thanks to a pilot research study by Imperial College which involves injecting a patient's stem cells into their brain.
Funded by the Wellcome Trust, researchers at Newcastle University have shown that, in monkeys, it is possible to restore hand and arm movement lost through brain damage.
Stroke survivors and healthcare professionals have identified problems with thinking and mood after stroke as some of the most important issues faced after a stroke. This Lectureship aims to test treatments to help stroke survivors with their cognitive (thinking) difficulties.
On 12 February 2015, at the International Stroke Conference (ISC 2015) in Nashville, USA, the findings of a Stroke Association-funded study were presented, called CADISS (Cervical Artery Dissection In Stroke Study).